Oncotarget

Research Perspectives:

Role of Pten in leukemia stem cells

Cong Peng, Yaoyu Chen, Dongguang Li and Shaoguang Li _

PDF  |  Order a Reprint

Oncotarget. 2010; 1:156-160. https://doi.org/10.18632/oncotarget.119

Metrics: PDF 2302 views  |   ?  


Abstract

Received: May 5, 2010, Accepted: May 18, 2010, Published: June 7, 2010

Chronic myeloid leukemia (CML) is initiated from the BCR-ABL-expressing leukemia stem cells (LSCs). These LSCs are highly resistant to BCR-ABL kinase inhibitors, imatinib, dasantinib and nilotinib, and methods for eradication of LSCs are still not available. It is critical to identify genes that play roles in survival and proliferation of LSCs. We recently discovered that the tumor suppressor gene Pten is downregulated in LSCs of CML mice. By genetic deletion or overexpression of Pten, we confirmed that Pten functions as a tumor suppressor in LSCs of CML, consistent with the role of Pten in LSCs of acute myeloid leukemia (AML) and progenitor cells of T-ALL progenitors. Functional enhancement of the Pten pathway provides a therapeutic strategy for targeting LSCs.

 


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 119